About the MEU

A Leader in First-In-Patient Studies

The Medicines Evaluation Unit (MEU) Ltd is one of the UK’s leading contract research organisations, and a facility where commitment to excellence is paramount. Possessing extensive pharmaceutical, scientific and clinical expertise, allied with fast volunteer recruitment, both healthy and patient, within a state-of-the-art hospital based research facility, enables the MEU to offer clients positive clinical trial solutions.

The MEU’s bespoke database and trial management system I.C.A.R.U.S. assists recruitment of the right patient to the right study, facilitating rapid enrolment, allowing us to meet our clients’ timelines.

The MEU holds MHRA Phase I Accreditation, together with an MHRA Manufacturing Assembly Licence, enabling the company to perform assembly activities. We can also offer a full CRO service with our well-established partners.

Phase 1 Accreditation

The MEU is an MHRA Phase 1 accredited unit and has been part of the scheme since its inception. This ensures that our studies are conducted to the highest standards in terms of both safety and quality.

MHRA Phase I Accreditation:
  • Accredited since July 2009
  • Most recent inspection February 2022 (No Criticals, No Majors)
ISO 9001 Accreditation:
  • Accredited since August 2011
  • Last ISO audit November 2020
ISO 27001 Accreditation:
  • Accredited since August 2022
  • Last ISO audit August 2023
MIA IMP Licence:
  • Licensed since April 2008
  • Last inspection 16 Oct 2013 (No Criticals, No Majors)
  • Current licence v5 issued 04 Nov 2013
  • GMP Compliance Statement issued 21 Nov 2013
MHRA GCP for Laboratories
Controlled Drugs Licence
Cyber Essentials
Cyber Essentials Plus
About the MEU